To further confirm the role of miR-103-3p/SATB2 axis in osteoporosis, miR-103-3p inhibitors and si-SATB2 were cotransfected with hBMSCs, effectively downregulating miR-103-3p and SATB2 (P < 0.05, Figure 4(f), 4(g)). The gene discussed is SATB2; the disease is osteoporosis.